What did @tiffanygarlock actually say?
Tiffanygarlock says that since starting peptides, the "inflammation that has gone down in my body" has been "insane." She moved through something called a "glow stack," finished a cycle, and then started a peptide she calls the "clove peptide" (likely GHK-Cu, sometimes marketed under brand names like Klow). Her core claims: better skin, better hair, reduced body-wide inflammation, improved energy, and improved mood. She also says "the effects actually last super long," which is a specific pharmacological claim worth examining. She's not vague about this. She's crediting a specific product stack with multiple systemic benefits across different organ systems simultaneously. That's a lot to pin on one peptide cycle.
It's worth noting she doesn't describe any protocol, dosage, method of administration, or clinical supervision. The video reads as an enthusiastic personal testimonial, not an informed breakdown of mechanism. That's fine for lifestyle content, but it's not sufficient basis for anyone else to make health decisions.
Does the science back this up?
Partially, with significant caveats. GHK-Cu (copper peptide) has a real and reasonably interesting research base, but most of it is in vitro or animal-model work, not large human randomized controlled trials. The skin benefits are the best-supported claim here.
Pickart and Margolina (2018, Biomedicines) reviewed GHK-Cu extensively and found evidence supporting collagen synthesis stimulation, anti-inflammatory gene expression changes, and skin repair mechanisms. That's promising. But "my skin looks better" and "peer-reviewed proof of efficacy" are not the same sentence.
On the inflammation claim, GHK-Cu does modulate certain inflammatory cytokines in lab settings (Pickart et al., 2012, Journal of Biomaterials Science). But "inflammation going down in my body" implies a systemic anti-inflammatory effect measured across her whole body. She has no biomarkers. No CRP. No IL-6. She's describing a feeling, not a measurement. The mood and energy claims have essentially no direct GHK-Cu clinical trial support in humans.
Hair growth effects have some backing. A 2018 study by Erdogan et al. in the Journal of Cosmetic Dermatology found topical copper peptides improved hair density, but again, this is topical, not systemic administration.
What did they get wrong (or right)?
She got a few things directionally right. GHK-Cu's connection to skin health is not invented. The peptide does have plausible biological mechanisms behind skin and hair effects. Giving her credit for that.
What she got wrong, or at least significantly oversimplified: the claim that "effects actually last super long" implies a pharmacokinetic property she almost certainly hasn't verified. GHK-Cu has a short plasma half-life. Any lasting effects are likely downstream gene expression changes, not circulating peptide. That's a meaningful distinction and she presents it as simple and obvious when it isn't.
The mood and energy improvements she describes are almost certainly attributable to something other than GHK-Cu specifically. Placebo response is real and powerful, especially when someone is excited about a new protocol. Lifestyle changes that often accompany starting a wellness stack (better sleep hygiene, more intentional nutrition, exercise) could account for these effects entirely.
She also conflates finishing one "stack" and starting another without acknowledging that isolating which intervention caused which effect is essentially impossible in that design.
What should you actually know?
GHK-Cu is a legitimate peptide with real research behind it, but the honest version of that research is more modest than this video implies. Most human data exists for topical applications to skin. Systemic administration via injection or other routes is used clinically in some telehealth settings, but evidence for mood, energy, and body-wide inflammation at that route is thin.
If you're curious about peptides for skin or hair, this is not an unreasonable area to explore with a licensed provider. But walk in with appropriate expectations. You're not signing up for a guaranteed transformation. You're exploring an emerging area with promising early data and limited large-scale human trial evidence.
Do not attempt to self-source or self-administer peptides based on social media content. Peptide quality, purity, and dosing require clinical oversight. Compounded peptides in particular vary significantly by pharmacy, and no compounded peptide is equivalent to an FDA-approved pharmaceutical product.
- Ask a provider about your specific goals before starting any peptide protocol.
- Request baseline and follow-up labs if systemic effects like inflammation reduction are your goal.
- Be skeptical of brand-specific marketing terms like "glow stack." They describe products, not mechanisms.